BCL11B and MTA2

  • Number of citations of the paper that reports this interaction (PMID 16091750)
  • 36

BCL11B

MTA2

Gene Name B-cell CLL/lymphoma 11B (zinc finger protein) metastasis associated 1 family, member 2
Image No pdb structure No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 9 interactors: CBX5 MBD3 MTA2 NR2F1 NR2F2 RBBP4 RBBP7 SP1 SUV39H1 21 interactors: APPL1 APPL2 BCL11B ESR1 FKBP3 HDAC2 HIST3H3 HNRNPD MBD3 MBD3L2 MED30 NACC2 RBBP4 RBBP7 SATB1 SATB2 SPEN TP53 TSC22D3 UBE3C YY1
Entrez ID 64919 9219
HPRD ID 05950 07233
Ensembl ID ENSG00000127152 ENSG00000149480
Uniprot IDs L8B567 L8B7P7 L8B862 L8B8F6 Q9C0K0 O94776
PDB IDs
Enriched GO Terms of Interacting Partners?
Tagcloud ?
cadherin  discovered  dnm2  druggable  exhibitedthe  fat1  fbxw7  frequencies  guide  harboured  herc1  jak  jak3  lymphoblastic  mll2  mutational  notch1  notch2  phf6  recurrent  regulators  reln  secretase  splicing  subclonal  unfavourable  warranted  wt1  zrsr2 
ag  ag1478  blocking  combat  combinatorial  dosage  egfr  exerts  fasn  greatly  hsp90  ideal  iialpha  iressa  isotope  labeling  lc  mechanistically  oncogenes  phosphatidylinositol  pi3k  pi4kiialpha  prdx2  presents  proteomic  silac  strengthened  ultimately  xenograft 
Tagcloud (Difference) ?
cadherin  discovered  dnm2  druggable  exhibitedthe  fat1  fbxw7  frequencies  guide  harboured  herc1  jak  jak3  lymphoblastic  mll2  mutational  notch1  notch2  phf6  recurrent  regulators  reln  secretase  splicing  subclonal  unfavourable  warranted  wt1  zrsr2 
ag  ag1478  blocking  combat  combinatorial  dosage  egfr  exerts  fasn  greatly  hsp90  ideal  iialpha  iressa  isotope  labeling  lc  mechanistically  oncogenes  phosphatidylinositol  pi3k  pi4kiialpha  prdx2  presents  proteomic  silac  strengthened  ultimately  xenograft 
Tagcloud (Intersection) ?